Chelsea Therapeutics Reports Third Quarter 2011 Results – msnbc.com

Posted on November 14, 2011 by admin

“People with symptomatic neurogenic orthostatic hypotension face extraordinary challenges every day,” commented Dr. Simon Pedder, President and CEO of Chelsea. “The filing of our new drug application during the third quarter was a significant … Bing News – Full Story →

Share

Related posts:

  1. Chelsea Therapeutics Reports Second Quarter 2011 Results – Yahoo Finance
  2. Chelsea Therapeutics to Host Conference Call to Discuss Third Quarter 2010 Results – msnbc.com
  3. Chelsea Therapeutics Announces Interim Results and Plans to Modify Study 306 to Focus on … – msnbc.com
  4. Chelsea Therapeutics to Present at 2010 Newsmakers in the Biotechnology Industry Conference – msnbc.com
  5. Cytokinetics, Incorporated Reports Third Quarter 2010 Financial Results – msnbc.com
This entry was posted in Autonomic Nervous System Disorders and tagged , , , , , , , . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>